Niquitin (Nicotine)

Nicotine, the active ingredient in Niquitin, is a nicotinic agonist presented as a transdermal patch for transdermal use. It is indicated for adult smokers who wish to quit, helping to alleviate nicotine withdrawal symptoms and reduce cravings during cessation attempts.

GNH USA supplies Niquitin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with distribution aligned to EU regulatory standards. The product meets European pharmacopoeial specifications and is manufactured under GMP conditions, ensuring consistent performance throughout its shelf life.

Niquitin (nicotine) is used in smoking cessation therapy to address nicotine dependence.

- Smoking cessation: supports adult smokers in quitting by mitigating withdrawal and cravings. - Nicotine dependence: reduces physiological need for nicotine in regular tobacco users. - Relapse prevention: helps maintain abstinence after initial quitting by providing controlled nicotine exposure.

Common Side Effects: - Skin irritation at the application site: redness, itching, or rash. - Insomnia: difficulty falling or staying asleep. - Vivid dreams: unusually intense or disturbing dreams. - Nausea: feeling of stomach upset. - Headache: mild to moderate head discomfort. - Dizziness: sensation of light‑headedness.

Serious or Rare Side Effects: - Allergic reaction: swelling, hives, or difficulty breathing. - Severe skin reaction: blistering or extensive dermatitis. - Tachycardia: abnormally fast heart rate. - Hypertension: elevated blood pressure. - Seizures: rare occurrence of convulsive episodes.

Before using Niquitin, consider the following safety measures.

- Cardiovascular assessment: evaluate history of heart disease or recent myocardial infarction. - Lowest effective dose: start with the smallest patch strength that provides symptom relief. - Non‑smoker use: avoid use in individuals who do not regularly smoke. - Pregnancy and lactation: only use if benefits outweigh potential risks. - Psychiatric monitoring: watch for mood changes or increased anxiety. - Store at room temperature: keep in the original packaging, protect from moisture and direct heat.

Niquitin may interact with other medicines; review the following.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): may increase risk of hypertensive crisis. - Concurrent nicotine products (gum, lozenge, inhaler): can cause nicotine overdose.

Moderate Interactions (Monitor Closely): - Antihypertensive agents: additive blood pressure‑lowering effect. - CYP2A6 inhibitors (e.g., certain antiretrovirals): may raise nicotine plasma levels. - Bupropion: combined use may raise seizure risk, requiring careful monitoring.